|
Vazyme Biotech Co
cell counting kit cck8 ![]() Cell Counting Kit Cck8, supplied by Vazyme Biotech Co, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/cck8+kit/CCK-8+Cell+Counting+Kit/pmc13763867-231-1-7 Average 98 stars, based on 1 article reviews
cell counting kit cck8 - by Bioz Stars,
2026-11
98/100 stars
|
Buy from Supplier |
|
Vazyme Biotech Co
cck8 ![]() Cck8, supplied by Vazyme Biotech Co, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/cck8+kit/CCK-8+Cell+Counting+Kit/pmc13760981-31-0-2 Average 98 stars, based on 1 article reviews
cck8 - by Bioz Stars,
2026-11
98/100 stars
|
Buy from Supplier |
|
Beyotime
cell counting kit 8 cck8 ![]() Cell Counting Kit 8 Cck8, supplied by Beyotime, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/cck8+kit/Cell+Counting+Kit-8/pm42967392-59-0-7 Average 99 stars, based on 1 article reviews
cell counting kit 8 cck8 - by Bioz Stars,
2026-11
99/100 stars
|
Buy from Supplier |
|
TargetMol
cell counting kit 8 cck8 reagent ![]() Cell Counting Kit 8 Cck8 Reagent, supplied by TargetMol, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/cck8+kit/Cell+Counting+Kit-8/pm42934272-98-16-21 Average 99 stars, based on 1 article reviews
cell counting kit 8 cck8 reagent - by Bioz Stars,
2026-11
99/100 stars
|
Buy from Supplier |
|
Beyotime
cck8 reagent ![]() Cck8 Reagent, supplied by Beyotime, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/cck8+kit/Cell+Counting+Kit-8/pm42893667-60-8-10 Average 99 stars, based on 1 article reviews
cck8 reagent - by Bioz Stars,
2026-11
99/100 stars
|
Buy from Supplier |
|
TargetMol
cck8 ![]() Cck8, supplied by TargetMol, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/cck8+kit/Cell+Counting+Kit-8/pm42881228-83-5-6 Average 99 stars, based on 1 article reviews
cck8 - by Bioz Stars,
2026-11
99/100 stars
|
Buy from Supplier |
|
Beyotime
cck8 detection cell viability ![]() Cck8 Detection Cell Viability, supplied by Beyotime, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/cck8+kit/Cell+Counting+Kit-8/pm42885281-122-0-13 Average 99 stars, based on 1 article reviews
cck8 detection cell viability - by Bioz Stars,
2026-11
99/100 stars
|
Buy from Supplier |
|
TargetMol
cell counting kit 8 cck8 ![]() Cell Counting Kit 8 Cck8, supplied by TargetMol, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/cck8+kit/Cell+Counting+Kit-8/pm42869007-1003-12-16 Average 99 stars, based on 1 article reviews
cell counting kit 8 cck8 - by Bioz Stars,
2026-11
99/100 stars
|
Buy from Supplier |
|
Beyotime
cck8 assay ![]() Cck8 Assay, supplied by Beyotime, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/cck8+kit/Cell+Counting+Kit-8/pm42867210-78-1-20 Average 99 stars, based on 1 article reviews
cck8 assay - by Bioz Stars,
2026-11
99/100 stars
|
Buy from Supplier |
Journal: International Journal of Molecular Sciences
Article Title: TRIM26-Mediated Ubiquitination and Degradation of DDRGK1 Suppress NSCLC Progression by Inhibiting DNA Repair and Promoting Apoptosis
doi: 10.3390/ijms272110014
Figure Lengend Snippet: DDRGK1 knockout increases the cytotoxic effect of cisplatin in NSCLC cells. ( A ) Gene Ontology (GO) and KEGG enrichment analysis of the 314 HCIPs of DDRGK1. DNA repair-related enriched pathways are highlighted in red. ( B ) DDRGK1 knockout A549 and H1299 cells were treated with cisplatin (20 μM, 12 h), and cell lysates were harvested for immunoblotting analysis. ( C ) DDRGK1 knockout A549 and H1299 cells were treated with cisplatin (20 μM, 48 h), and cell lysates were harvested for immunoblotting analysis. ( D ) DDRGK1 knockout A549 and H1299 cells were treated with cisplatin (20 μM, 48 h), and cells were harvested for Annexin V-FITC/PI staining and flow cytometry analysis (mean ± SD independent biological experiments; n = 3 independent biological experiments; two-way ANOVA). ( E ) Cell viability was assessed by CCK8 assay in DDRGK1 knockout A549 and H1299 cells at 48 h after cisplatin treatment. In A549 cells, the cisplatin IC50 was 4.10 μM (sgCtrl), 2.70 μM (sgDDRGK1-1#), and 2.60 μM (sgDDRGK1-2#) ( p = 0.0002; F (4,54) = 6.538; extra sum-of-squares F test). In H1299 cells, the IC50 was 7.38 μM (sgCtrl), 3.98 μM (sgDDRGK1-1#), and 4.41 μM (sgDDRGK1-2#) (p < 0.0001; F (4,54) = 12.52; extra sum-of-squares F test). Data are presented as mean ± SD, n = 4 independent biological experiments. ( F ) The plate colony formation detection clonogenic ability of DDRGK1 knockout A549 and H1299 cells under cisplatin treatment (mean ± SD; n = 3 independent biological experiments; two-way ANOVA). ( G ) The DDRGK1 knockout A549 cells and control cells were subcutaneously injected into 6-week-old male BALB/c nude mice. At 14 days after injection, mice received intraperitoneal injections of cisplatin (5 mg/kg) or saline every 3 days, with 5 injections in total. Tumors were harvested, and the tumor weight was calculated (mean ± SD; n = 6 independent biological experiments; two-way ANOVA).
Article Snippet: The
Techniques: Knock-Out, Analysis, Western Blot, Staining, Flow Cytometry, CCK-8 Assay, Colony Assay, Control, Injection, Saline
Journal: iScience
Article Title: PADI2 facilitates progression and cisplatin resistance of epithelial ovarian cancer via m6A methylation
doi: 10.1016/j.isci.2026.118100
Figure Lengend Snippet: Downregulating PADI2 and METTL3 suppresses colony formation, proliferation, and apoptosis of A2780 and SKOV3 cells (A) Relative RNA level of PADI2 in A2780 and SKOV3 upon PADI2 and METTL3 knockdown. (B) Western blot detected the protein level of PADI2 in A2780 and SKOV3 cells upon PADI2 and METTL3 knockdown. (C) EdU proliferation of A2780 and SKOV3 cells after PADI2 and METTL3 knockdown. A2780 and SKOV3 cells were treated as indicated and stained for EdU incorporation (Red) or DAPI (blue) to highlight nuclei (scale bars, 50 μm). EdU-positive A2780 and SKOV3 cells ratio is shown on top. All data are expressed as the mean ± SD of values from triplicate experiments. ∗ p < 0.05, ∗∗ p < 0.01, and ∗∗∗ p < 0.001 compared with control group. (D) The apoptotic levels of A2780 and SKOV3 after knockdown of PADI2 and METTL3 were measured by using the Annexin V-FITC cell apoptosis detection kit. (E) Colony formation assays were performed to detect the long-term proliferation capacity of A2780 and SKOV3 cells with PADI2 and METTL3 knockdown. (F) CCK-8 assay illustrated the proliferative ability and IC50 with PADI2 knockdown at different concentrations of cDDP. Ns for statistical significance, ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, and ∗∗∗∗ p < 0.0001. Data are represented as mean ± SD ( n = 3 per group). One-way ANOVA for (A).
Article Snippet:
Techniques: Colony Assay, Knockdown, Western Blot, Staining, EdU Assay, Control, CCK-8 Assay
Journal: iScience
Article Title: PADI2 facilitates progression and cisplatin resistance of epithelial ovarian cancer via m6A methylation
doi: 10.1016/j.isci.2026.118100
Figure Lengend Snippet: Ablation of METTL3 significantly suppresses EOC cell proliferation and METTL3 and YTHDF2 recognize and regulate m6A in PADI2 mRNA (A) A correlation analysis conducted using Spearman’s rank correlation coefficient. (B) Relative RNA level of PADI2 in A2780 and SKOV3 upon YTHDF2 knockdown. (C) Western blot detected the protein level of PADI2 in A2780 and SKOV3 cells upon YTHDF2 knockdown. (D) CCK8 assays were performed upon YTHDF2 knockdown in A2780 and SKOV3 cells. (E) YTHDF2 depletion impairs the colony-forming ability of EOC cells. (F) Schematic representation of wild-type (PADI2-wt) and mutant (PADI2-mut) PADI2 constructs. (G) Relative activity of the wild-type or mutant promoter luciferase reporter in 293T cells expressing PADI2 protein. (H) MeRIP-qPCR indicated the enrichment of PADI2 mRNA in SKOV3 cells using m6A antibody. (I) RNA decay rate assay demonstrated that PADI2 mRNA half-lives were significantly shortened upon the YTHDF2 knockdown. (J) RIP-qPCR indicated the enrichment of PADI2 mRNA in SKOV3 cells, using anti-YTHDF2 antibody. (K) RIP-qPCR indicated the enrichment of PADI2 mRNA in SKOV3 cells, using anti-YTHDF2 antibody, with METTL3 knockdown. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, and ∗∗∗∗ p < 0.0001. Data are represented as mean ± SD ( n = 3 per group). Statistical significance in this figure was determined using one-way ANOVA.
Article Snippet:
Techniques: Analysis, Knockdown, Western Blot, Mutagenesis, Construct, Activity Assay, Luciferase, Expressing
Journal: iScience
Article Title: PADI2 facilitates progression and cisplatin resistance of epithelial ovarian cancer via m6A methylation
doi: 10.1016/j.isci.2026.118100
Figure Lengend Snippet:
Article Snippet:
Techniques: